120 related articles for article (PubMed ID: 720482)
21. Dopamine receptor binding in bovine intermediate lobe pituitary membranes.
Sibley DR; Creese I
Endocrinology; 1980 Nov; 107(5):1405-9. PubMed ID: 7428676
[TBL] [Abstract][Full Text] [Related]
22. Thermodynamic analysis of antagonist and agonist interactions with dopamine receptors.
Duarte EP; Oliveira CR; Carvalho AP
Eur J Pharmacol; 1988 Mar; 147(2):227-39. PubMed ID: 2452751
[TBL] [Abstract][Full Text] [Related]
23. D2- but not D3-dopamine receptors detected in the anterior pituitary.
Titeler M; Van Loon GR; Seeman P; Brown GM
Eur J Pharmacol; 1981 Apr; 71(1):143-6. PubMed ID: 7238583
[TBL] [Abstract][Full Text] [Related]
24. [3H] spiroperidol binding to brain neurotransmitter receptors.
Withy RM; Mayer RJ; Strange PG
FEBS Lett; 1980 Apr; 112(2):293-5. PubMed ID: 6154601
[No Abstract] [Full Text] [Related]
25. Irreversible blockade of [3H]spiperone- but not [3H]dopamine-labeled dopamine receptors with phenoxybenzamine.
Titeler M
Biochem Pharmacol; 1981 Nov; 30(22):3031-7. PubMed ID: 7337719
[No Abstract] [Full Text] [Related]
26. Multiple dopamine binding sites: subcellular localization and biochemical characterization.
Clement-Cormier YC; George RJ
J Neurochem; 1979 Mar; 32(3):1061-9. PubMed ID: 430039
[No Abstract] [Full Text] [Related]
27. Immuno-photoaffinity labeling of the D2-dopamine receptor.
Kanety H; Fuchs S
Biochem Biophys Res Commun; 1988 Sep; 155(2):930-6. PubMed ID: 2458727
[TBL] [Abstract][Full Text] [Related]
28. Dopamine receptors in the central nervous system.
Seeman P; Tedesco JL; Lee T; Chau-Wong M; Muller P; Bowles J; Whitaker PM; McManus C; Tittler M; Weinreich P; Friend WC; Brown GM
Fed Proc; 1978 Feb; 37(2):131-6. PubMed ID: 414936
[TBL] [Abstract][Full Text] [Related]
29. Affinities of drugs for the agonist and antagonist states of the dopamine receptor.
Riddall DR; Leavens WJ
Eur J Pharmacol; 1978 Sep; 51(2):187-8. PubMed ID: 699984
[No Abstract] [Full Text] [Related]
30. A rapid and simple method for assaying 3H-spiroperidol binding to solubilized dopamine receptors.
Varmuza S; Mishra RK
Pharmacol Res Commun; 1981 Jun; 13(6):587-605. PubMed ID: 6170077
[No Abstract] [Full Text] [Related]
31. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
Neve KA; Altar CA; Wong CA; Marshall JF
Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
[TBL] [Abstract][Full Text] [Related]
32. Identification and partial purification of a hydrophobic protein component associated with [3H]spiroperidol-binding activity.
Boyan-Salyers BD; Clement-Cormier Y
Biochim Biophys Acta; 1980 Feb; 617(2):274-81. PubMed ID: 7357020
[TBL] [Abstract][Full Text] [Related]
33. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
[TBL] [Abstract][Full Text] [Related]
34. Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drug.
Seeman P; Chau-Wong M; Tedesco J; Wong K
Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4354-8. PubMed ID: 12505
[TBL] [Abstract][Full Text] [Related]
35. Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors.
Köhler C; Fuxe K; Ross SB
Eur J Pharmacol; 1981 Jul; 72(4):397-402. PubMed ID: 7274333
[TBL] [Abstract][Full Text] [Related]
36. Heat treatment mimics guanosine-5'-triphosphate effects on dopaminergic 3H-ligand binding to bovine caudate membranes.
Hamblin MW; Creese I
Mol Pharmacol; 1982 Jan; 21(1):52-6. PubMed ID: 7132962
[TBL] [Abstract][Full Text] [Related]
37. Direct evidence for presynaptic and postsynaptic dopamine receptors in brain.
Nagy JI; Lee T; Seeman P; Fibiger HC
Nature; 1978 Jul; 274(5668):278-81. PubMed ID: 683308
[No Abstract] [Full Text] [Related]
38. 3H-Apomorphine interactions with dopamine receptors in calf brain.
Thal L; Creese I; Snyder SH
Eur J Pharmacol; 1978 Jun; 49(3):295-9. PubMed ID: 658143
[TBL] [Abstract][Full Text] [Related]
39. Dopamine receptors in the Parkinsonian brain.
Rinne UK; Lönnberg P; Koskinen V
J Neural Transm; 1981; 51(1-2):97-106. PubMed ID: 6114985
[TBL] [Abstract][Full Text] [Related]
40. Estrogen inhibits the dopaminergic supersensitivity induced by neuroleptics.
Fields JZ; Gordon JH
Life Sci; 1982 Jan; 30(3):229-34. PubMed ID: 7200183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
